Big Pharma’s Control Over The News

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
100
Big Pharma’s Control Over The News

https://www.naturalblaze.com/2017/12/big-phar...-news.html

By Jon Rappoport

Over the last 11 months, pharmaceutical companies have spent a stunning $3.2 billion on TV ads for drugs.

That much money buys you influence. It buys you control.

If a major network suddenly decided to set its hounds loose and investigate the overall devastating effects of medical drugs on the public, there would be hell to pay at the network. Drug companies wouldn’t stand for it.

Robert F Kennedy, Jr., whose film, Trace Amounts, about toxic mercury in vaccines, was getting no media coverage, made this comment:

“I talked to Roger Ailes [then CEO of FOX News], who I have known since I was 17 years old, he’s very sympathetic with this issue and saw the film Trace Amounts. I said to him, ‘I just want to go on one of your shows. Nobody will allow me to talk about this or debate me.’ He said to me, ‘I can’t allow you on any of them. I’d have to fire any of my hosts that allowed you on my station.’ Because he said, ‘My news division gets up to 70% of advertising revenues during non-election years from the pharmaceutical companies’.”

That’s called control.

There is a wider sphere to consider. Through octopus foundations like Rockefeller and Gates, for example, the medical/pharma agenda is part and parcel of the Globalist agenda. That is key. Gathering in the world population under the umbrella of “humanitarian health care” is a covert op of the highest order.

How can you control billions of people, erase national borders, destroy untold numbers of communities and their traditions, wage senseless wars, send millions of jobs out of industrial countries to Third World backwaters, and build a de facto global management system—unless you can also debilitate, weaken, confuse, toxify, and thus pacify those billions of people?

Accomplishing this is the work of the pharmaceutical empire.

I have produced, many times, open-source mainstream reviews of the death and damage numbers wrought by “Rockefeller medicine.” In the US, 106,000 deaths every year from government-approved medicines. In the US and Europe, 330,000 die, every year, from correctly prescribed drugs. 6.6 million hospitalizations occur. 80 million adverse effects occur. These are conservative estimates.

So…what is the likelihood that pharma-controlled mainstream news will dig deeply into the issue of Globalism, the major tyrannical movement of our time?

The likelihood is zero.

The influence of pharmaceutical interests on the news is, therefore, much greater than most people can fathom, in their wildest dreams.

Most people, when confronted with these pharmaceutical death-and-destruction reports, will immediately dismiss them as impossible. Others, who accept the reports, will claim the “unfortunate” facts show no intention to harm whatsoever.

However, the reports are public knowledge. They’ve been available to one and all. Government officials—and particularly, pharma princes—know the truth. And they’re doing nothing about it.

This is called a clue.

If you were in charge of a juggernaut operation that was causing this much horrific damage, and you knew it, would you stand by and let it keep happening? Would you foster the development of new drugs whose effects would only add to the ongoing tragedy? And would you exert such powerful control over major media that the truth could not be told?

I didn’t think so.

The pharma princes are not like you. You can’t see who they are if you look through the lens of your morality. They don’t share that morality. They don’t resemble you. Don’t ascribe your qualities to them. They don’t respond to life as you do. Their capacity for self-deception is awesome. Your good is not their good.

It is as if they were born freezing and never recovered. They come from an Ice Age and their blood is still cold.

They are rigid robots. Muscular truth can take them down.

Read More: https://investorshangout.com/post/view?id=488...z51O3uv37F
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Keller Joins JC Behavioral Health Council, RCA Shines

Updated Category News Views 50

RCA's Role in Behavioral Health Standards Kendall Keller just grabbed a prime seat at a table that could shape the future of behavioral healthcare in the U.S. Appointed to the Joint Commission’s (JC) Behavioral Health Care & Human Services Advisory Council, Keller isn’t lounging around. Here’s someone with 18 years under her belt, tasked with steering the ship for...

Continue Reading
Broadway.com Instagram Reaches Million Followers Milestone

Updated Category News Views 54

Broadway.com's Instagram Ascends to Iconic Status There it is, folks—Broadway.com's Instagram just threw down the gauntlet with a clean, million-follower milestone. That's right, a hefty chunk of people now have a front-row seat to Broadway's electric world, straight from their phones. If you're a Broadway buff or just a casual admirer of glitz and glam, these numbers...

Continue Reading
AI, GLP-1, and the Food Revolution Unveiled

Updated Category News Views 123

How the Food Industry Faces a Formulation Shake-Up In a world where diets are shifting like never before, food companies are adjusting their game plans or risk getting left in the dust. With one in five U.S. households reportedly housing a GLP-1 user by May 2026, the food game looks more like a strategic chess match than ever. Balancing taste, nutrition, and price is no...

Continue Reading
Ball Corp to Steal the Spotlight at 2026 Baird Event

Updated Category News Views 69

Ball Corporation's Big Moment at Baird 2026 Did you hear the rumble in the aluminum jungle? That's Ball Corporation (NYSE: BALL) gearing up to take the stage at the Baird 2026 Global Industrial Conference on November 12. The big wigs, Ron Lewis and Dan Rabbitt, CEO and CFO respectively, will throw down some serious wisdom at 7:55 a.m. Central Time. What'll they cover?...

Continue Reading
Wood Partners Expands Charlotte Footprint with New Project

Updated Category News Views 59

Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 115

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
Why Haunted Attractions Keep Us Coming Back for Fear

Updated Category News Views 90

Welcome to Fear Incarnated Ah, Kansas City. More than just jazz and barbeque. You’ve got these infamous haunted houses that turn every horror flick into a mere Saturday morning cartoon. Enter Edge of Hell and Beast Haunted Attraction. Two horrifying museums of fear that somehow lure us like flies to sugar from miles away. What's the secret sauce? Well, that’s half the...

Continue Reading
ZKONG, Hagebau Push ESLs in European Retail Revamp

Updated Category News Views 98

ESLs: The Next Step in Retail Revamp Here’s the scoop: ZKONG and hagebau are making waves in the retail scene over in Germany. They’re bringing in Electronic Shelf Labels (ESLs) to kick traditional price tags to the curb. What started as a shake-up in supermarkets now rolls into the world of home improvement retail—headline by hagebaumarkt in Selb after nearly half...

Continue Reading
Reducto Office Transforms Document Editing with AI

Updated Category News Views 53

AI Meets Full-Fidelity Document Editing Gone are the days when AI could only analyze documents. With Reducto Office's latest plugin, the AI's stepping right into the editing game. For free, they say! Built smack-dab into ChatGPT and Codex, this plugin lets users work their AI magic on Word docs, PowerPoint presentations, and Excel spreadsheets. And the kicker? You can see...

Continue Reading
Landstar Faces Legal Storm Post Earnings Miss

Updated Category News Views 17

Landstar's Earnings Misstep Sends Shockwaves Alright, let's talk about this snafu at Landstar (NASDAQ: LSTR). They were supposed to deliver an earnings sheet that's all roses, but instead, we got a couple of thorns. Analysts were expecting them to strike gold with EPS numbers between $1.62 to $1.67. What we got? A measly $1.42. Not exactly the shiny haul we were led to...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Hiring Surge Fuels May Job Growth in the US

Updated Category News Views 10

The Rising Tide of Tech Employment The momentum keeps rolling in the tech sector with employment figures that would make any investor take notice. The data just out from CompTIA highlights a significant uptick in tech occupation employment for May. A whooping 69,000 more tech workers found jobs, bringing the total across the nation to 5.9 million. Given the roiling...

Continue Reading
Quoin Pharmaceuticals Secures $104.5 Million in Financing

Updated Category News Views 260

Quoin Pharmaceuticals Secures Major Financial Investment Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a company dedicated to developing treatments for rare and orphan diseases, has taken a significant step forward by announcing a private placement financing of up to $104.5 million. This funding includes an initial investment of $16.5 million, with the potential for an...

Continue Reading
Simplilearn's Rise as a Premier IT Training Provider

Updated Category News Views 162

Simplilearn's Rise as a Premier IT Training Provider Simplilearn, a renowned leader in digital upskilling, is thrilled to be acknowledged among the top IT training providers. This recognition emphasizes their ongoing commitment to delivering advanced and comprehensive training tailored to meet the demands of the tech landscape. Celebrating Outstanding Contributions For...

Continue Reading
Zeta Global Seeks Investors for Class Action Participation

Updated Category News Views 210

Understanding the Ongoing Class Action Against Zeta Global Faruqi & Faruqi LLP, a prominent national securities law firm, is currently leading an investigation into potential claims against Zeta Global Holdings Corp. (NYSE: ZETA). This investigation is raising awareness among investors who may have suffered financial losses involving Zeta Global. If you believe your...

Continue Reading
Chevron-Hess Merger Approval: Investment Insights and Outlook

Updated Category News Views 244

The Chevron-Hess Merger: A Turning Point for Investors In the fast-paced world of investments, significant developments at Chevron Corporation (NYSE: CVX) and Hess Corp. (NYSE: HES) are capturing attention. The recent approval of their merger by the U.S. Federal Trade Commission (FTC) could reshape the oil landscape, marking an important moment for investors considering...

Continue Reading